ATE260663T1 - Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort - Google Patents

Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort

Info

Publication number
ATE260663T1
ATE260663T1 AT96916194T AT96916194T ATE260663T1 AT E260663 T1 ATE260663 T1 AT E260663T1 AT 96916194 T AT96916194 T AT 96916194T AT 96916194 T AT96916194 T AT 96916194T AT E260663 T1 ATE260663 T1 AT E260663T1
Authority
AT
Austria
Prior art keywords
steroids
promoting
pharmaceutical compositions
immune response
substituted
Prior art date
Application number
AT96916194T
Other languages
English (en)
Inventor
Robert Morfin
Jorge Ronco
Original Assignee
Mayoly Spindler Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayoly Spindler Lab filed Critical Mayoly Spindler Lab
Application granted granted Critical
Publication of ATE260663T1 publication Critical patent/ATE260663T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
AT96916194T 1995-05-11 1996-05-10 Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort ATE260663T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9505607A FR2733912B1 (fr) 1995-05-11 1995-05-11 Compositions pharmaceutiques contenant des derives de steroides impliques dans le declenchement de la reponse immunitaire
PCT/FR1996/000719 WO1996035428A1 (fr) 1995-05-11 1996-05-10 Compositions pharmaceutiques contenant des derives de steroides impliques dans le declenchement de la reponse immunitaire

Publications (1)

Publication Number Publication Date
ATE260663T1 true ATE260663T1 (de) 2004-03-15

Family

ID=9478893

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916194T ATE260663T1 (de) 1995-05-11 1996-05-10 Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort

Country Status (6)

Country Link
EP (1) EP0844879B1 (de)
AT (1) ATE260663T1 (de)
CA (1) CA2235110C (de)
DE (1) DE69631770D1 (de)
FR (1) FR2733912B1 (de)
WO (1) WO1996035428A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000511404A (ja) 1996-04-09 2000-09-05 ビー・テイー・ジー・インターナシヨナル・リミテツド 神経精神、免疫又は内分泌障害を治療するための７α置換ステロイドの使用
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
AU1822600A (en) * 1998-11-19 2000-06-05 Mrs, Llc Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
JP2004537506A (ja) 2001-03-01 2004-12-16 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 血液細胞欠乏症を治療するためのある種のステロイドの使用
WO2006110172A2 (en) 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals.Inc. Steroid analogs and characterization and treatment methods

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.

Also Published As

Publication number Publication date
EP0844879A1 (de) 1998-06-03
WO1996035428A1 (fr) 1996-11-14
EP0844879B1 (de) 2004-03-03
FR2733912A1 (fr) 1996-11-15
FR2733912B1 (fr) 1997-07-18
DE69631770D1 (de) 2004-04-08
CA2235110C (fr) 2004-05-04
CA2235110A1 (fr) 1996-11-14

Similar Documents

Publication Publication Date Title
NZ241211A (en) 16alpha,17alpha-alkylidenedioxy-11b,21-dihydroxypregan -4-ene-3,20-dione derivatives substituted by halogen in either or both of the 6alpha- or the 9alpha- position; pharmaceutical compositions, methods of preparation and treatment
FI935306A0 (fi) Anvaendning av renade, ytmodifierande aemnen foer att hindra aggregation av partiklar under sterilisation
ID28003A (id) Turunan-turunan adamantana
ATE306931T1 (de) Unterdrückung von veränderungen in zusammenhang mit beta-amyloid bei alzheimer
DK1036058T3 (da) Adamantanderivater
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
GB8830380D0 (en) New derivatives of 17beta-oh 19-nor steroids substituted in the 17alpha position,their preparation,their use as medicaments and pharmaceutical compositions
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
ATE260663T1 (de) Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
FI956029A0 (fi) Androstaanisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
HUP0202931A2 (hu) Egy gyógyszerészetileg hatásos összetétel és a beadására szolgáló készülék
DK0719276T3 (da) Ïstradiolestre med stærk oral virkning samt farmaceutiske præparater med indhold deraf
FI956028A (fi) Estreenisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
ATE109137T1 (de) Pyridinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ATE279198T1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
EP0456842A4 (en) Medicinal application of m-csf
ES2161809T3 (es) Uso de factor proliferativo osteoblastico.
EP0579765A4 (en) Method and composition for the treatment of herpes related disorders
DE69313534D1 (de) Digitoxigenin und Dihydrodigitoxigenin 3-beta-Derivate und pharmazeutische Präparate davon, zur Behandlung von hypertonie
AU4123297A (en) Alkaloid glycoside for use as a medicament
NO931208L (no) Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike
CO4180553A1 (es) Composiciones para el tratamiento de la peridontitis adulta

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties